The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York FDA Denies Approval of Roxadustat for Anemia in CKD MPR Kidney Toxicity (Drug Induced Nephrotoxicity) In Dogs PetlifeSA Dihexa 1mL(10 mM in DMSO) Neurotrophic Peptide Enhancer APExBIO A Rare Case of Kidney Failure Due to Diazoxide Toxicity Discussion. PPT WO2014052766A1 Hepatocyte growth factor mimics as therapeutic agents Google Patents